Infergen

Active Ingredient(s): Interferon Alfacon-1
FDA Approved: * October 6, 1997
Pharm Company: * INTERMUNE PHARMS
Category: Hepatitis

Interferon alfacon-1 is a recombinant synthetic type I interferon used for the treatment of hairy cell leukemia, malignant melanoma and AIDS-related Kaposi's sarcoma.[1] References ^ DrugBank DB00069 .mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbo... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Infergen .03 mg/ml Subcutaneous Injection

NDC: 66435-201

Labeler:

Kadmon Pharmaceuticals, LLC

Infergen .03 mg/ml Subcutaneous Injection

NDC: 66435-202

Labeler:

Kadmon Pharmaceuticals, LLC